No Data
Press Release: Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Olema Pharmaceuticals Secures Major Partnership and Funding
Express News | Olema Pharmaceuticals Inc - Well Capitalized to Fund Operations Beyond Key Milestones
Express News | Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement
Citi Remains a Buy on Olema Pharmaceuticals (OLMA)